Synthetic cathinones are lab-made stimulant drugs chemically related to cathinone, a naturally occurring substance found in the khat plant. Often sold under the street name “bath salts,” they produce effects similar to methamphetamine, cocaine, and MDMA. These drugs are structurally modified versions of amphetamine, with a small chemical tweak that earns them the technical name “beta-keto amphetamines.” That single change is enough to create a wide family of compounds with varying potency and unpredictable effects.
How They Relate to the Khat Plant
The khat plant (Catha edulis) grows in East Africa and the Arabian Peninsula, where people have chewed its leaves or brewed them into tea for centuries to get mild stimulant effects similar to caffeine. Cathinone is the main psychoactive ingredient in those leaves. Synthetic cathinones take that natural molecule as a starting template and alter it in a lab, producing dozens of distinct compounds that are far more potent than anything the plant delivers on its own.
Common Compounds and Street Names
The synthetic cathinone family includes many individual drugs, but a few have dominated the market. MDPV (3,4-methylenedioxypyrovalerone) was one of the original ingredients in products labeled “bath salts” and sold under names like Ivory Wave and Vanilla Sky. Alpha-PVP, known as “flakka,” is a close chemical relative that gained notoriety for causing extreme agitation and bizarre public behavior. Mephedrone, sometimes called “Meow Meow” or “Drone,” was especially popular in the UK club scene before being banned. Methylone, pentedrone, and eutylone are other variants that have circulated widely.
New compounds appear regularly. Because chemists can make small structural changes to create technically novel substances, the list of synthetic cathinones keeps growing, often outpacing the laws designed to control them.
How They Are Used
Synthetic cathinones typically come as white or brown powders, though they also appear as crystals, tablets, and capsules. The most common routes are swallowing (in capsule form or wrapped in paper) and snorting the powder. Some users inject the drugs intravenously or intramuscularly. Effects generally kick in within a few minutes to 15 minutes depending on the method, and they can last up to three hours. Some synthetic cathinones are also sold disguised as ecstasy pills, meaning users may not even know what they’re taking.
What They Do to the Brain
Like other stimulants, synthetic cathinones flood the brain with chemical messengers, particularly dopamine and serotonin. Depending on the specific compound, they either block the recycling of these messengers (so they build up between nerve cells) or actively force extra release. The dopamine surge is what produces the intense euphoria and energy. The serotonin effects can create feelings of emotional closeness and sensory distortion, similar to MDMA.
The problem is that different synthetic cathinones hit these systems with very different intensity. MDPV and alpha-PVP, for example, are extremely potent blockers of dopamine recycling, which is why they tend to produce the most severe agitation and paranoia. Users have no reliable way to know which compound is in the product they buy, or how strong it is.
Short-Term Effects and Dangers
The desired effects include euphoria, increased energy, heightened alertness, and feelings of sociability. The adverse effects, however, can be severe and unpredictable.
Data from U.S. poison centers illustrate how common serious reactions are. In reports from Kentucky and Louisiana poison centers during 2010 and 2011, 82% of cases involved agitation, 57% involved combative behavior, 56% had rapid heart rate, 40% experienced hallucinations, and 36% reported paranoia. A separate analysis of calls to Texas poison centers found rapid heart rate in 46% of cases, agitation in 39%, high blood pressure in 21%, and hallucinations in 18%.
A large UK survey of mephedrone users found that 41% reported depression after use, 26% reported overheating, 23% experienced agitation, 12% had severe headaches, and 10% had chest pain. Seizures, nausea, vomiting, suicidal thoughts, and violent outbursts have all been documented as well. The paranoia can be extreme enough to cause people to harm themselves or attack others.
Long-Term Health Risks
Repeated use of synthetic cathinones can damage the brain, heart, kidneys, and lungs. Research in animals has shown that mephedrone exposure during adolescence caused DNA damage in the brain’s frontal cortex that persisted into adulthood. Methylone has been shown to destroy dopamine and serotonin nerve terminals in the frontal cortex and hippocampus, two areas critical for decision-making and memory. MDPV caused measurable loss of connectivity between brain regions involved in motivation and reward, and repeated use appears to compromise cognitive function and cause neurodegeneration.
Human fatality cases have revealed fatty liver disease, kidney tissue death, brain swelling, lung hemorrhage, and enlarged hearts at autopsy. These findings span multiple different synthetic cathinones, suggesting that organ damage is a class-wide risk rather than limited to one or two compounds. Hyperthermia (dangerously elevated body temperature) and neuroinflammation are two of the most direct pathways through which these drugs harm the brain. In the most severe cases, a condition called excited delirium syndrome can develop, combining extreme agitation, high body temperature, and organ failure, sometimes fatally.
Legal Status in the United States
In 2012, the Synthetic Drug Abuse Prevention Act placed mephedrone and MDPV into Schedule I, the most restrictive category of controlled substances. Since then, the DEA has permanently added methylone and 10 other synthetic cathinones through administrative scheduling. N-ethylpentylone was controlled in 2018, and six more compounds, including alpha-PHP and N-ethylhexedrone, were temporarily controlled in 2019.
For newer compounds that haven’t been individually scheduled, the Federal Analog Act allows prosecutors to treat any substance that is “substantially similar” in chemistry or effect to a Schedule I drug as if it were also Schedule I. This is the legal mechanism designed to keep up with the constant stream of new variants, though enforcement depends on meeting specific criteria in each case.
Current Trends
Synthetic cathinone submissions to DEA forensic laboratories have generally trended downward since 2020. There was a slight uptick in 2023, with nearly 13,200 submissions, but 2024 saw a significant drop to approximately 7,300 submissions. This suggests that while synthetic cathinones remain in circulation, their prevalence in the U.S. drug supply has declined from the peak years of the early 2010s. They continue to pose risks, however, particularly when sold as other drugs like ecstasy or mixed into unknown powders, leaving users unaware of what they’re consuming.